Biotechnology to Address the Challenges of Antimicrobial Resistance
A special issue of Biologics (ISSN 2673-8449).
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 766
Special Issue Editor
Interests: antimicrobial resistance; animal-alternative laboratory models of host–pathogen interaction; disease interventions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The emerging challenge of antimicrobial resistance (AMR) represents a global threat to the effective prevention and treatment of infections caused by viruses, bacteria, fungi, and parasites. By 2050, the deaths associated with AMR could reach 700 million with an associated cost of $14 billion (KPMG, 2014). In this Special Issue, we wish to explore biotechnological approaches to addressing the challenges of AMR. All aspects of biologics derived from both novel and established biotechnologies are within our scope insofar as they relate to AMR. We particularly welcome submissions covering:
- Natural antimicrobials derived from living systems, especially plants and bacteriophages.
- (Bio)synthesis of antimicrobials.
- Biologics to remove/inhibit biofilm formation.
KPMG (2014). The global economic impact of antibiotic resistance. London: KPMG.
Prof. Dr. Mark Chambers
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biologics is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Antimicrobials
- Biofilms
- Biosynthesis
- Biotechnology
- Phytochemistry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
